~~<i id='B242E00FE9'><strike id='B242E00FE9'><tt id='B242E00FE9'><pre id='B242E00FE9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：focus 2025-09-29 01:06:14 - browse：16

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： The untold story of TV’s first prescription drug ad

knowledge

entertainment

hotspot

focus

knowledge

StatuesoftheGreekphysicianHippocrates.AdobeOnJan.22,1973,theU.S.SupremeCourthandeddownitsdecisioninR

WSS

New rules on organ donation and transplantation 'will bring chaos'

As Taiwan prepares for anti

HIPAA doesn't protect reproductive records from prosecutors

How artificial intelligence is being used to detect, treat cancer

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Wikipedia

knowledge

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

State of the Union pitch: Bigger Medicare drug price negotiations

After affirmative action ruling, medical educators look to 'holistic review'

First over

What does generative AI mean for health care? We asked experts

He's 19 months old and has one of the world’s rarest diseases

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: BridgeBio, Akero, and human embryo models

Continuity nursing helped my family in our darkest PICU moments

What to know about Saharan dust affecting the US and how it can affect health

entertainment

What to know about Saharan dust affecting the US and how it can affect health

Medicare drug price negotiation continues, as pharma counteroffers

The untold story of TV’s first prescription drug ad

The public health thinking behind the CDC’s new Covid guidance

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Longer MASH drug regimen improved liver, Akero study finds

entertainment

hotspot

focus

knowledge